Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
about
A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.Regulation of circulating progenitor cells in left ventricular dysfunction.Designer natriuretic peptides.Recent advances in natriuretic peptides in congestive heart failure.Dendroaspis natriuretic peptide regulates the cardiac L-type Ca2+ channel activity by the phosphorylation of α1c proteins.Natriuretic peptides and the dialysis patient.Cardiovascular and metabolic effects of natriuretic peptides.Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.Novel therapeutic directions for the natriuretic peptides in cardiovascular diseases: what's on the horizon.Natriuretic peptides and therapeutic applications.Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.Insights into natriuretic peptides in heart failure: an update.Modulation of cGMP in heart failure: a new therapeutic paradigm.CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease.Novel vasodilators in heart failure.Natriuretic Peptides as a Novel Target in Resistant Hypertension.Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 1--Cardiac diseases and pulmonary hypertension.Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.Novel bifunctional natriuretic peptides as potential therapeutics.Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice.Dendroaspis natriuretic peptide administered intracerebroventricularly increases renal water excretion.Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.
P2860
Q33577067-8AB1959C-6D99-42FD-ACFF-1685A97EC7ADQ34305164-C891FEE5-2E5C-4DF2-B9AB-FB117CB4EE7FQ34989233-9B143E81-8F92-4C04-9CC6-964A467C26E5Q35086479-D4C46AE0-9CAA-408A-9839-5F5A25C4689CQ35790792-68515765-74BA-46C0-834D-38F9C36D2846Q36074060-5238ECB8-CE4D-4126-96AA-12C6A8554B8CQ36271152-5A12C96B-6185-4DF2-910D-770A68BF613BQ36382621-D30205AC-CC0A-43A0-9EAD-1C5344783E40Q36528021-D110249C-6AF5-43E7-BC3A-FFE23504B9CAQ36669295-2064BD78-7D34-41AE-A85C-35E507903560Q36794409-D3A1DDC0-E7AE-4C22-93A2-B7D7578458ADQ36954799-66E03AC3-4301-4112-ABB1-34F131D4CC59Q37217952-5413646E-A9D0-4225-8986-AF49075BCABFQ37258795-F95C40A0-64BE-4EAD-8891-F84A9666A30EQ37329891-82BB3D94-C284-48BE-92B9-DDD4D2B01136Q37768079-0FE8A1CB-740E-496D-82AE-745ED44EAF22Q38072635-4427D54E-8ECC-4A48-91A2-DEA545357614Q38371173-0984FFA9-FF50-4A81-8A05-4C1F9E05A478Q38514901-24DD274E-DE67-4E2C-804F-3389669264BEQ38750251-083384E1-EF27-4293-8314-25F1F9116889Q40455345-023C3FDB-AB5A-4A44-AD99-68F2B04C5D9CQ40590132-E9AF02EE-AE43-45A9-9DB2-52FF3B73529DQ43925194-048BE5AF-C495-4EDD-965A-696156FA4AB2Q48386405-00AB9FAA-E5BA-4443-BF3D-4C59427E794D
P2860
Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Therapeutic actions of a new s ...... vere congestive heart failure.
@en
Therapeutic actions of a new s ...... vere congestive heart failure.
@nl
type
label
Therapeutic actions of a new s ...... vere congestive heart failure.
@en
Therapeutic actions of a new s ...... vere congestive heart failure.
@nl
prefLabel
Therapeutic actions of a new s ...... vere congestive heart failure.
@en
Therapeutic actions of a new s ...... vere congestive heart failure.
@nl
P2093
P356
P1433
P1476
Therapeutic actions of a new s ...... vere congestive heart failure.
@en
P2093
H Leskinen
J C Burnett
J G Lainchbury
P304
P356
10.1161/01.HYP.37.4.1089
P407
P577
2001-04-01T00:00:00Z